Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T8CE
|
||||
Former ID |
DNCL002631
|
||||
Drug Name |
AMG888/U3-1287
|
||||
Indication | Non-small cell lung cancer [ICD10:C33-C34] | Phase 1/2 | [523187] | ||
Company |
Amgen
|
||||
Target and Pathway | |||||
Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | Modulator | [543486] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
EGF receptor signaling pathway | |||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
ErbB receptor signaling network | |||||
a6b1 and a6b4 Integrin signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.